Oramed to Present at ThinkEquity Conference

NEW YORK, April 29, 2019 /PRNewswire/ — Oramed Pharmaceuticals Inc. (NASDAQ: ORMP) (TASE: ORMP) (www.oramed.com), a clinical-stage pharmaceutical company focused on the development of oral drug delivery systems, announced today that it will participate in the upcoming ThinkEquity Conference on May 2, 2019 in New York City. Nadav Kidron, CEO of Oramed, will present a corporate overview.  Presentation […]